Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -620 | -410 | -370 | -1,140 | -250 |
| Depreciation Amortization | 100 | 80 | 60 | 200 | 130 |
| Other Working Capital | -1,030 | -1,000 | -630 | -1,190 | -610 |
| Other Operating Activity | 240 | 410 | 430 | 1,230 | 200 |
| Operating Cash Flow | $-1,310 | $-920 | $-510 | $-900 | $-530 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -30 | -140 | -40 |
| Other Investing Activity | 1,340 | 660 | 20 | -3,710 | -3,710 |
| Investing Cash Flow | $1,310 | $630 | $-10 | $-3,850 | $-3,750 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -6 | -6 | -6 | 5,960 | 5,980 |
| Financing Cash Flow | $-6 | $-6 | $-6 | $5,960 | $5,980 |
| Beginning Cash Position | 1,280 | 1,280 | 1,280 | 80 | 80 |
| End Cash Position | 1,270 | 980 | 750 | 1,290 | 1,770 |
| Net Cash Flow | $-10 | $-300 | $-530 | $1,200 | $1,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,310 | -920 | -510 | -900 | -530 |
| Free Cash Flow | -1,310 | -920 | -510 | -900 | -530 |